Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holub

Showing results (1161-1170 of 1,215) with videos related to

Pageof 122
Sort By:
The American Journal of Medicine|May 12, 2024
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDHarlan M Krumholz, Mitsuaki Sawano, Bornali Bhattacharjee, et al.
Scientific Data|May 8, 2024
Getting your DUCs in a row - standardising the representation of Digital Use ConditionsFrancis Jeanson, Spencer J Gibson, Pinar Alper, et al.
The Lancet. Infectious Diseases|February 22, 2025
Mycoplasma pneumoniae infection in adult inpatients during the 2023-24 outbreak in France (MYCADO): a national, retrospective, observational studyAriane Gavaud, Matthieu Holub, Antoine Asquier-Khati, et al.
Molecules (Basel, Switzerland)|November 17, 2007
Lipid-lowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole- 4-carboxylates in rodentsJustin M Holub, Kathy O'Toole-Colin, Adam Getzel, et al.
Brain Communications|July 26, 2023
Associations between sleep health and grey matter volume in the UK Biobank cohort (<i>n</i> = 33 356)Julian E Schiel, Sandra Tamm, Florian Holub, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Somatic variants activating the RAS-MAPK pathway confer susceptibility to hippocampal sclerosis in drug-resistant epilepsyLauren Mashburn-Warren, Ashton Holub, Sahibjot Sran, et al.
The Lancet. Infectious Diseases|April 6, 2025
Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trialMitsuaki Sawano, Bornali Bhattacharjee, César Caraballo, et al.
Global Change Biology|April 4, 2017
Asymmetric responses of primary productivity to precipitation extremes: A synthesis of grassland precipitation manipulation experimentsKevin R Wilcox, Zheng Shi, Laureano A Gherardi, et al.
Transplantation Research|July 3, 2013
Extended pancreas donor program - the EXPAND study rationale and study protocolAndrea Proneth, Andreas A Schnitzbauer, Florian Zeman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis ConsortiumB Weinstock-Guttman, L D Jacobs, C M Brownscheidle, et al.
Pageof 122

Showing results (1161-1170 of 1,215) with videos related to

Sort By:
Pageof 122
The American Journal of Medicine|May 12, 2024
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDHarlan M Krumholz, Mitsuaki Sawano, Bornali Bhattacharjee, et al.
Scientific Data|May 8, 2024
Getting your DUCs in a row - standardising the representation of Digital Use ConditionsFrancis Jeanson, Spencer J Gibson, Pinar Alper, et al.
The Lancet. Infectious Diseases|February 22, 2025
Mycoplasma pneumoniae infection in adult inpatients during the 2023-24 outbreak in France (MYCADO): a national, retrospective, observational studyAriane Gavaud, Matthieu Holub, Antoine Asquier-Khati, et al.
Molecules (Basel, Switzerland)|November 17, 2007
Lipid-lowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole- 4-carboxylates in rodentsJustin M Holub, Kathy O'Toole-Colin, Adam Getzel, et al.
Brain Communications|July 26, 2023
Associations between sleep health and grey matter volume in the UK Biobank cohort (<i>n</i> = 33 356)Julian E Schiel, Sandra Tamm, Florian Holub, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Somatic variants activating the RAS-MAPK pathway confer susceptibility to hippocampal sclerosis in drug-resistant epilepsyLauren Mashburn-Warren, Ashton Holub, Sahibjot Sran, et al.
The Lancet. Infectious Diseases|April 6, 2025
Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trialMitsuaki Sawano, Bornali Bhattacharjee, César Caraballo, et al.
Global Change Biology|April 4, 2017
Asymmetric responses of primary productivity to precipitation extremes: A synthesis of grassland precipitation manipulation experimentsKevin R Wilcox, Zheng Shi, Laureano A Gherardi, et al.
Transplantation Research|July 3, 2013
Extended pancreas donor program - the EXPAND study rationale and study protocolAndrea Proneth, Andreas A Schnitzbauer, Florian Zeman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis ConsortiumB Weinstock-Guttman, L D Jacobs, C M Brownscheidle, et al.
Pageof 122